No. 3: The year of big pharma In the past five years,
big cap pharmaceutical stocks have lagged biotech stocks because they've struggled to fill revenue gaps created by the patent cliff.
Not exact matches
The
biggest company in Canada by market
cap on the TSX — an admittedly capricious metric — is now Valeant
Pharmaceuticals, which surpassed the Royal Bank of Canada this week.
Dollar Bill plans a
big short position on a
pharmaceutical company stock, but not everyone at Axe
Cap approves.